The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Adrenergic and Reflex Abnormalities in Obesity-Related Hypertension
Open accessAbstract
Abstract —Previous studies have shown that essential hypertension and obesity are both characterized by sympathetic activation coupled with a baroreflex impairment. The present study was aimed at determining the effects of the concomitant presence of the 2 above-mentioned conditions on sympathetic activity as well as on baroreflex cardiovascular control. In 14 normotensive lean subjects (aged 33.5±2.2 years, body mass index 22.8±0.7 kg/m 2 [mean±SEM]), 16 normotensive obese subjects (body mass index 37.2±1.3 kg/m 2 ), 13 lean hypertensive subjects (body mass index 24.0±0.8 kg/m 2 ), and 16 obese hypertensive subjects (body mass index 37.5±1.3 kg/m 2 ), all age-matched, we measured beat-to-beat arterial blood pressure (by Finapres device), heart rate (HR, by ECG), and postganglionic muscle sympathetic nerve activity (MSNA, by microneurography) at rest and during baroreceptor stimulation and deactivation induced by stepwise intravenous infusions of phenylephrine and nitroprusside, respectively. Blood pressure values were higher in lean hypertensive and obese hypertensive subjects than in normotensive lean and obese subjects. MSNA was significantly ( P <0.01) greater in obese normotensive subjects (49.1±3.0 bursts per 100 heart beats) and in lean hypertensive subjects (44.5±3.3 bursts per 100 heart beats) than in lean normotensive control subjects (32.2±2.5 bursts per 100 heart beats); a further increase was detectable in individuals with the concomitant presence of obesity and hypertension (62.1±3.4 bursts per 100 heart beats). Furthermore, whereas in lean hypertensive subjects, only baroreflex control of HR was impaired, in obese normotensive subjects, both HR and MSNA baroreflex changes were attenuated, with a further attenuation being observed in obese hypertensive patients. Thus, the association between obesity and hypertension triggers a sympathetic activation and an impairment in baroreflex cardiovascular control that are greater in magnitude than those found in either of the above-mentioned abnormal conditions alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“elevation in subcutaneous adiposity does not alter the baroreflex.”
From Rapid Onset of Renal Sympathetic Nerve Activation in Rabbits Fed a High-Fat Diet (2012) · cites this paper as [31]
In the citing paper
“The hypertension in obesity is characterized by a reduction in baroreceptor inhibition in humans 31 when there is significant visceral adiposity”
From Rapid Onset of Renal Sympathetic Nerve Activation in Rabbits Fed a High-Fat Diet (2012) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sympathetic neural mechanisms in obstructive sleep apnea.
Somers, V. K., Dyken, M. E., Clary, M. P., & Abboud, F. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118235 · Cited by 2,527
Guilleminault, C., Tilkian, A., & Dement, W. C. (1976) · Annual Review of Medicine · doi:10.1146/annurev.me.27.020176.002341 · Cited by 1,812
Parati, G., Casadei, R., Groppelli, A., Di Rienzo, M., & Mancia, G. (1989) · Hypertension · doi:10.1161/01.hyp.13.6.647 · Cited by 899
Self-citationOverflow of catecholamine neurotransmitters to the circulation: source, fate, and functions
Esler, M., Jennings, G., Lambert, G., Meredith, I., Horne, M., & Eisenhofer, G. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.4.963 · Cited by 794
Anderson, E. A., Sinkey, C. A., Lawton, W. J., & Mark, A. L. (1989) · Hypertension · doi:10.1161/01.hyp.14.2.177 · Cited by 632
Sympathetic Activation in Obese Normotensive Subjects
Grassi, G., Seravalle, G., Cattaneo, B. M., Bolla, G. B., Lanfranchi, A., Colombo, M., Giannattasio, C., Brunani, A., Cavagnini, F., & Mancia, G. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.560 · Cited by 614
Self-citationPlasma catecholamines and essential hypertension. An analytical review.
Goldstein, D. S. (1983) · Hypertension · doi:10.1161/01.hyp.5.1.86 · Cited by 598
Hjemdahl, P., Daleskog, M., & Kahan, T. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90384-9 · Cited by 564
Sleep Apnea and Hypertension: A Population-based Study
Hla, K. M., Young, T. B., Bidwell, T., Palta, M., Skatrud, J. B., & Dempsey, J. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-5-199403010-00005 · Cited by 551
Baroreflex Control of Sympathetic Nerve Activity in Essential and Secondary Hypertension
Grassi, G., Cattaneo, B. M., Seravalle, G., Lanfranchi, A., & Mancia, G. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.68 · Cited by 526
Self-citation
Research works printed but not linked: 11
- 10.1161/circ.89.6.8205675 · DOI
- 10.1161/hyp.25.4.560 · DOI
- 10.1161/circ.96.10.3423 · DOI
- 10.1161/hyp.31.1.68 · DOI
- 10.1161/hyp.27.2.276 · DOI
- 10.1161/circ.92.11.3206 · DOI
- 10.1161/circ.82.3.2394007 · DOI
- 10.1161/circ.96.11.4104 · DOI
- 10.1161/circ.98.8.772 · DOI
- 10.1161/res.43.2.97032 · DOI
- Mancia G Zanchetti A. Hypothalamic control of autonomic functions. In: Panksepp PJ Morgane J eds. Handbook of Hypothalamus. New York NY: Marcel Dekker Inc; 1981:147–202.
Cited by
Sorted by citations
2013 ESH/ESC Guidelines for the management of arterial hypertension
Authors Task Force Members, Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., Christiaens, T., Cífková, R., Backer, G. D., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,739
Self-citationMancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
Self-citationMancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Self-citationVinik, A. I., Maser, R. E., Mitchell, B. D., & Freeman, R. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1553 · Cited by 2,044
Seravalle, G., & Grassi, G. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.013 · Cited by 909
Self-citation2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension
Mancia, G., Fagard, R. H., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T. C., Cífková, R., Backer, G. D., Dominiczak, A. F., et al. (2013) · Blood Pressure · doi:10.3109/08037051.2014.868629 · Cited by 749
Self-citationSympathetic Nervous System Overactivity and Its Role in the Development of Cardiovascular Disease
Malpas, S. C. (2010) · Physiological Reviews · doi:10.1152/physrev.00007.2009 · Cited by 696
Daskalopoulou, S. S., Rabi, D. M., Zarnke, K. B., Dasgupta, K., Nerenberg, K. A., Cloutier, L., Gelfer, M., Lamarre-Cliché, M., Milot, A., Bolli, P., et al. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.02.016 · Cited by 690
The Autonomic Nervous System and Hypertension
Mancia, G., & Grassi, G. (2014) · Circulation Research · doi:10.1161/circresaha.114.302524 · Cited by 627
Self-citationThe Sympathetic Nervous System Alterations in Human Hypertension
Grassi, G., Mark, A., & Esler, M. (2015) · Circulation Research · doi:10.1161/circresaha.116.303604 · Cited by 616
Self-citationThe pathophysiology of hypertension in patients with obesity
DeMarco, V. G., Aroor, A. R., & Sowers, J. R. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.44 · Cited by 545
Obesity, Sleep Apnea, and Hypertension
Wolk, R., Shamsuzzaman, A. S. M., & Somers, V. K. (2003) · Hypertension · doi:10.1161/01.hyp.0000101686.98973.a3 · Cited by 532
Relevance of Sympathetic Nervous System Activation in Obesity and Metabolic Syndrome
Thorp, A. A., & Schlaich, M. P. (2015) · Journal of Diabetes Research · doi:10.1155/2015/341583 · Cited by 425
2013 ESH/ESC Guidelines for the management of arterial hypertension
Mancia, G., Fagard, R. H., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T. C., Cífková, R., Backer, G. D., Dominiczak, A. F., et al. (2013) · Blood Pressure · doi:10.3109/08037051.2013.812549 · Cited by 430
Self-citationThe sympathetic nervous system and the metabolic syndrome
Mancia, G., Bousquet, P., Elghozi, J. L., Esler, M., Grassi, G., Julius, S., Reid, J., & Van Zwieten, P. A. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e328048d004 · Cited by 385
Self-citationEisenhofer, G. (2001) · Pharmacology and Therapeutics · doi:10.1016/s0163-7258(01)00144-9 · Cited by 373
Assessment of Sympathetic Cardiovascular Drive in Human Hypertension
Grassi, G. M. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.119883 · Cited by 340
Self-citationGrassi, G. M., Dell’Oro, R., Facchini, A., Trevano, F. Q., Bolla, G. B., & Mancia, G. (2004) · Journal of Hypertension · doi:10.1097/00004872-200412000-00019 · Cited by 339
Self-citationArterial Stiffening Precedes Systolic Hypertension in Diet-Induced Obesity
Weisbrod, R. M., Shiang, T., Al Sayah, L., Fry, J. L., Bajpai, S., Reinhart-King, C. A., Lob, H. E., Santhanam, L., Mitchell, G., Cohen, R. A., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01744 · Cited by 317
Prolonged Activation of the Baroreflex Produces Sustained Hypotension
Lohmeier, T. E., Irwin, E. D., Rossing, M. A., Serdar, D. J., & Kieval, R. S. (2004) · Hypertension · doi:10.1161/01.hyp.0000111837.73693.9b · Cited by 283
Obesity and hypertension: two epidemics or one?
Davy, K. P., & Hall, J. E. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00707.2003 · Cited by 280
Is obesity a major cause of chronic kidney disease?
Hall, J. E., Henegar, J. R., Dwyer, T. M., Liu, J., da Silva, A. A., Kuo, J. J., & Tallam, L. (2004) · Advances in Renal Replacement Therapy · doi:10.1053/j.arrt.2003.10.007 · Cited by 264
Lambert, É. (2011) · Frontiers in Physiology · doi:10.3389/fphys.2011.00052 · Cited by 243
Obesity and adipokines: effects on sympathetic overactivity
Smith, M. M., & Minson, C. T. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.221036 · Cited by 245
Grassi, G., Seravalle, G., Dell'Oro, R., Trevano, F. Q., Bombelli, M., Scopelliti, F., Facchini, A., & Mancia, G. (2003) · Journal of Hypertension · doi:10.1097/00004872-200309000-00027 · Cited by 225
Self-citationSympathetic Nervous System and Blood Pressure in Humans
Joyner, M. J., Charkoudian, N., & Wallin, B. G. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.140186 · Cited by 221
Obstructive Sleep Apnea–Dependent and –Independent Adrenergic Activation in Obesity
Grassi, G. M., Facchini, A., Trevano, F. Q., Dell’Oro, R., Arenare, F., Tana, F., Bolla, G. B., Monzani, A., Robuschi, M., & Mancia, G. (2005) · Hypertension · doi:10.1161/01.hyp.0000174243.39897.6c · Cited by 214
Self-citationHuggett, R. J., Burns, J., Mackintosh, A. F., & Mary, D. A. S. G. (2004) · Hypertension · doi:10.1161/01.hyp.0000147893.08533.d8 · Cited by 211
Differing Pattern of Sympathoexcitation in Normal-Weight and Obesity-Related Hypertension
Lambert, E., Straznicky, N., Schlaich, M., Esler, M., Dawood, T., Hotchkin, E., & Lambert, G. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.094649 · Cited by 195
Insulin resistance and the sympathetic nervous system
Egan, B. M. (2003) · Current Hypertension Reports · doi:10.1007/s11906-003-0028-7 · Cited by 172
Sympathetic nervous system behavior in human obesity
Davy, K. P., & Orr, J. S. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.05.024 · Cited by 166
Jordan, J., Yumuk, V., Schlaich, M. P., Nilsson, P. M., Zahorska‐Markiewicz, B., Grassi, G. M., Schmieder, R. E., Engeli, S., & Finer, N. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283537347 · Cited by 156
Self-citationSympathetic Nerve Traffic Activation in Essential Hypertension and Its Correlates
Grassi, G. M., Pisano, A., Bolignano, D., Seravalle, G., D’Arrigo, G., Quarti‐Trevano, F., Mallamaci, F., Zoccali, C., & Mancia, G. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11038 · Cited by 142
Self-citationReduced cardiovagal baroreflex gain in visceral obesity: implications for the metabolic syndrome
Beske, S. D., Alvarez, G. E., Ballard, T. P., & Davy, K. P. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00642.2001 · Cited by 143
Mano, T., Iwase, S., & Toma, S. (2006) · Clinical Neurophysiology · doi:10.1016/j.clinph.2006.06.002 · Cited by 138
Sympathetic Neural Overdrive in the Obese and Overweight State
Grassi, G. M., Biffi, A., Seravalle, G., Trevano, F. Q., Dell’Oro, R., Corrao, G., & Mancia, G. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.12885 · Cited by 135
Self-citationFreeman, R. L. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53480-4.00006-0 · Cited by 137
The sympathetic nervous system and long-term blood pressure regulation
Lohmeier, T. E. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02082-9 · Cited by 133
Valensi, P. E. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01356-w · Cited by 145
Sympathetic Overdrive and Cardiovascular Risk in the Metabolic Syndrome
Grassi, G. M. (2006) · Hypertension Research · doi:10.1291/hypres.29.839 · Cited by 131
Self-citationPontiroli, A. E., Folli, F., Paganelli, M., Micheletto, G., Pizzocri, P., Vedani, P., Luisi, F., Perego, L., Morabito, A., & Bressani Doldi, S. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2703 · Cited by 129
Systemic and Renal-Specific Sympathoinhibition in Obesity Hypertension
Lohmeier, T. E., Iliescu, R., Liu, B., Henegar, J. R., Maric-Bilkan, C., & Irwin, E. D. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.185074 · Cited by 130
The Baroreflex as a Long-Term Controller of Arterial Pressure
Lohmeier, T. E., & Iliescu, R. (2015) · Physiology · doi:10.1152/physiol.00035.2014 · Cited by 126
Perego, L., Pizzocri, P., Corradi, D., Maisano, F., Paganelli, M., Fiorina, P., Barbieri, M., Morabito, A., Paolisso, G., Folli, F. B., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1963 · Cited by 126
Altered renal sodium handling in men with abdominal adiposity: a link to hypertension
Strazzullo, P., Barba, G., Cappuccio, F. P., Siani, A., Trevisan, M., Farinaro, E., Pagano, E., Barbato, A., Iacone, R., & Galletti, F. (2001) · Journal of Hypertension · doi:10.1097/00004872-200112000-00007 · Cited by 124
Gender differences in sympathetic nervous activity: influence of body mass and blood pressure
Lambert, É., Straznicky, N. E., Eikelis, N., Esler, M., Dawood, T., Masuo, K., Schlaich, M. P., & Lambert, G. W. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281053af4 · Cited by 123
Prolonged Activation of the Baroreflex Abolishes Obesity-Induced Hypertension
Lohmeier, T. E., Dwyer, T. M., Irwin, E. D., Rossing, M. A., & Kieval, R. S. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.087874 · Cited by 118
Grassi, G. M., Seravalle, G., Scopelliti, F., Dell’Oro, R., Fattori, L., Quarti‐Trevano, F., Brambilla, G., Schiffrin, E. L., & Mancia, G. (2009) · Obesity · doi:10.1038/oby.2009.195 · Cited by 119
Self-citationShould the sympathetic nervous system be a target to improve cardiometabolic risk in obesity?
Lambert, É., Straznicky, N. E., Dixon, J. B., & Lambert, G. W. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00096.2015 · Cited by 117
Marked sympathetic activation and baroreflex dysfunction in true resistant hypertension
Grassi, G. M., Seravalle, G., Brambilla, G., Pini, C., Alimento, M., Facchetti, R., Spaziani, D., Cuspidi, C., & Mancia, G. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.09.138 · Cited by 118
Self-citationMuscle metaboreflex control is diminished in normotensive obese women
Negrão, C. E., Trombetta, I. C., Batalha, L. T., Ribeiro, M. M., Rondon, M. U. P. B., Tinucci, T., Forjaz, C. L. M., Barretto, A. C. P., Halpern, A., & Villares, S. M. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.2.h469 · Cited by 116
Rapid Onset of Renal Sympathetic Nerve Activation in Rabbits Fed a High-Fat Diet
Armitage, J. A., Burke, S. L., Prior, L. J., Barzel, B., Eikelis, N., Lim, K., & Head, G. A. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.190413 · Cited by 115
Recent insights into the interactions between the baroreflex and the kidneys in hypertension
Lohmeier, T. E., Hildebrandt, D. A., Warren, S., May, P. J., & Cunningham, J. T. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00591.2004 · Cited by 113
Influence of Prolonged Baroreflex Activation on Arterial Pressure in Angiotensin Hypertension
Lohmeier, T. E., Dwyer, T. M., Hildebrandt, D. A., Irwin, E. D., Rossing, M. A., Serdar, D. J., & Kieval, R. S. (2005) · Hypertension · doi:10.1161/01.hyp.0000187011.44201.2e · Cited by 110
Sympathetic nervous system as a target for aging and obesity-related cardiovascular diseases
Balasubramanian, P., Hall, D., & Subramanian, M. (2018) · GeroScience · doi:10.1007/s11357-018-0048-5 · Cited by 111
Impact of the obesity epidemic on hypertension and renal disease
Hall, J. E., Jones, D. W., Kuo, J. J., da Silva, A. A., Tallam, L. S., & Liu, J. (2003) · Current Hypertension Reports · doi:10.1007/s11906-003-0084-z · Cited by 106
Charkoudian, N., & Wallin, B. G. (2014) · Comprehensive physiology · doi:10.1002/cphy.c130038 · Cited by 111
Impact of Leptin-Mediated Sympatho-Activation on Cardiovascular Function in Obese Mice
Belin de Chantemèle, E. J., Mintz, J. D., Rainey, W. E., & Stepp, D. W. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.168427 · Cited by 103
Effects of Hypertension and Obesity on the Sympathetic Activation of Heart Failure Patients
Grassi, G. M., Seravalle, G., Quarti‐Trevano, F., Dell’Oro, R., Bolla, G. B., & Mancia, G. (2003) · Hypertension · doi:10.1161/01.hyp.0000098660.26184.63 · Cited by 100
Self-citationHesse, C., Charkoudian, N., Liu, Z., Joyner, M. J., & Eisenach, J. H. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.090308 · Cited by 99
Altered Renal Handling of Sodium in Human Hypertension
Strazzullo, P., Galletti, F., & Barba, G. (2003) · Hypertension · doi:10.1161/01.hyp.0000066844.63035.3a · Cited by 95
Sustained Activation of the Central Baroreceptor Pathway in Angiotensin Hypertension
Lohmeier, T. E., Lohmeier, J. R., Warren, S., May, P. J., & Cunningham, J. T. (2002) · Hypertension · doi:10.1161/hy0202.103003 · Cited by 97
Holwerda, S. W., Restaino, R. M., Manrique, C. M., Lastra, G., Fisher, J. P., & Fadel, P. J. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00636.2015 · Cited by 99
Lambert, É., & Lambert, G. W. (2011) · Current Hypertension Reports · doi:10.1007/s11906-011-0186-y · Cited by 99
Modest weight gain is associated with sympathetic neural activation in nonobese humans
Gentile, C. L., Orr, J. S., Davy, B. M., & Davy, K. P. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00876.2006 · Cited by 92
Counteracting the sympathetic nervous system in essential hypertension
Grassi, G. M. (2004) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200409000-00006 · Cited by 89
Self-citationNew developments in the pathogenesis of obesity-induced hypertension
Kotsis, V., Nilsson, P. M., Grassi, G. M., Mancia, G., Redón, J., Luft, F., Schmieder, R. E., Engeli, S., Stabouli, S., Antza, C., et al. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000645 · Cited by 91
Self-citationHypertension and the Metabolic Syndrome
Morse, S. A., Zhang, R., Thakur, V., & Reisin, E. (2005) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200512000-00008 · Cited by 88
Therapeutic strategies for targeting excessive central sympathetic activation in human hypertension
Fisher, J. P., & Fadel, P. J. (2010) · Experimental Physiology · doi:10.1113/expphysiol.2009.047332 · Cited by 85
Influence of Sibutramine on blood pressure: evidence from placebo-controlled trials
Jordan, J., Scholze, J. E., Matiba, B., Wirth, A. G., Hauner, H., & Sharma, A. M. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802887 · Cited by 84
Obesity as a premature aging phenotype — implications for sarcopenic obesity
Nunan, E. L., Wright, C. L., Semola, O. A., Subramanian, M., Balasubramanian, P., Lovern, P. C., Fancher, I. S., & Butcher, J. T. (2022) · GeroScience · doi:10.1007/s11357-022-00567-7 · Cited by 83
Heart Rate, Sympathetic Cardiovascular Influences, and The Metabolic Syndrome
Grassi, G. M., Arenare, F., Quarti‐Trevano, F., Seravalle, G., & Mancia, G. (2009) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.05.007 · Cited by 79
Self-citationAT1-receptor antagonism reverses the blood pressure elevation associated with diet-induced obesity
Boustany, C. M., Brown, D. R., Randall, D. C., & Cassis, L. A. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00507.2004 · Cited by 76
Leptin Impairs Cardiovagal Baroreflex Function at the Level of the Solitary Tract Nucleus
Arnold, A. C., Shaltout, H. A., Gallagher, P. E., & Diz, D. I. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.138065 · Cited by 71
Sympathetic nervous system and hypertension: New evidences
Seravalle, G., & Grassi, G. M. (2022) · Autonomic Neuroscience · doi:10.1016/j.autneu.2022.102954 · Cited by 79
Self-citationAngiotensin–sympathetic system interactions in cardiovascular and metabolic disease
Mancia, G., Dell’Oro, R., Quarti‐Trevano, F., Scopelliti, F., & Grassi, G. M. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000220407.84363.fb · Cited by 72
Self-citationDoes the sympathetic nervous system contribute to the pathophysiology of metabolic syndrome?
Moreira, M. C. D. S., Pinto, I. S. D. J., Mourão, A. A., Fajemiroye, J. O., Colombari, E., Reis, Â. A. D. S., Freiria-Oliveira, A. H., Neto, M. L. F., & Pedrino, G. R. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00234 · Cited by 78
Device-Based Neuromodulation for Resistant Hypertension Therapy
Lohmeier, T. E., & Hall, J. E. (2019) · Circulation Research · doi:10.1161/circresaha.118.313221 · Cited by 74
2013 ESH/ESC Guidelines for the management of arterial hypertension
(2013) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.07.015 · Cited by 70
Consequences of Comorbid Sleep Apnea in the Metabolic Syndrome— Implications for Cardiovascular Risk
Trombetta, I. C., Somers, V. K., Maki‐Nunes, C., Drager, L. F., Toschi‐Dias, E., Alves, M. J. N. N., Fraga, R. F., Rondon, M. U. P. B., Bechara, M. G., Lorenzi‐Filho, G., et al. (2010) · SLEEP · doi:10.1093/sleep/33.9.1193 · Cited by 69
Macefield, V. G. (2020) · Clinical Autonomic Research · doi:10.1007/s10286-020-00700-6 · Cited by 67
Seravalle, G., Lonati, L. M., Buzzi, S., Cairo, M., Trevano, F. Q., Dell’Oro, R., Facchetti, R., Mancia, G., & Grassi, G. M. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000567 · Cited by 68
Self-citationImpairment of sympathetic baroreceptor reflexes in obese Zucker rats
Schreihofer, A. M., Mandel, D. A., Mobley, S. C., & Stepp, D. W. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01201.2006 · Cited by 67
Huber, D. A., & Schreihofer, A. M. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2009.186387 · Cited by 65
Reduced plasma volume and mesenteric vascular reactivity in obese Zucker rats
Schreihofer, A. M., Hair, C. D., & Stepp, D. W. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00498.2004 · Cited by 63
Machleidt, F., Simon, P., Krapalis, A. F., Hallschmid, M., Lehnert, H., & Sayk, F. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3009 · Cited by 61
The Sympathetic Nervous System in Obesity Hypertension
Lohmeier, T. E., & Iliescu, R. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0356-1 · Cited by 62
Cardiovascular risk and adrenergic overdrive in the metabolic syndrome
Grassi, G. M., Quarti‐Trevano, F., Seravalle, G., & Dell’Oro, R. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.01.004 · Cited by 61
Self-citationRaising lipids acutely reduces baroreflex sensitivity
Gadegbeku, C. A., Dhandayuthapani, A., Sadler, Z. E., & Egan, B. M. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)02275-6 · Cited by 59
Strand, A. H., Gudmundsdottir, H., Os, I., Smith, G., Westheim, A. S., Bjørnerheim, R., & Kjeldsen, S. E. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000222761.07477.7b · Cited by 58
Influence of sibutramine treatment on sympathetic vasomotor tone in obese subjects
Heusser, K., Tank, J., Diedrich, A., Engeli, S., Klaua, S., KRUGER, N., Strauss, A., STOFFELS, G., Luft, F. C., & JORDAN, J. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.02.002 · Cited by 57
Metabolic syndrome and renal sodium handling in three ethnic groups living in England
Barbato, A., Cappuccio, F. P., Folkerd, E. J., Strazzullo, P., Sampson, B., Cook, D. G., & Alberti, K. G. M. M. (2004) · Diabetologia · doi:10.1007/s00125-003-1260-z · Cited by 55
Ross, E. L., Heizer, J. W., Mixon, M. A., Jorgensen, J. E., Valdez, C. A., Czaja, A. S., & Reiter, P. D. (2015) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp140280 · Cited by 54
Pontiroli, A. E., Pizzocri, P., Saibene, A., Girola, A., Koprivec, D., & Fragasso, G. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802733 · Cited by 54
Immunosuppression of Macrophages Underlies the Cardioprotective Effects of CST (Catestatin)
Ying, W., Tang, K., Avolio, E., Schilling, J. M., Pasqua, T., Liu, M. A., Cheng, H., Gao, H., Zhang, J., Mahata, S., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.16809 · Cited by 48
Increased sympathetic response to standing in panic disorder
Coupland, N. J., Wilson, S. J., Potokar, J. P., Bell, C., & Nutt, D. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(03)00045-3 · Cited by 52
Holwerda, S. W., Vianna, L. C., Restaino, R. M., Chaudhary, K. R., Young, C. N., & Fadel, P. J. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00384.2016 · Cited by 54
Lindgren, K., Hagelin, E., Hansén, N., & Lind, L. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000198024.91976.c2 · Cited by 50
Weight loss increases cardiovagal baroreflex function in obese young and older men
Alvarez, G. E., Davy, B. M., Ballard, T. P., Beske, S. D., & Davy, K. P. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00487.2004 · Cited by 50
da Silva, A. A., Kuo, J. J., Tallam, L. S., & Hall, J. E. (2004) · Hypertension · doi:10.1161/01.hyp.0000111139.94378.74 · Cited by 49
Metadata
- Authors
- Grassi, G., Seravalle, G., Dell’Oro, R., Turri, C., Bolla, G. B., & Mancia, G.
- Affiliations
- IRCCS Istituto Auxologico Italiano (IT)
- Venue
- Hypertension
- Published
- 2000-10
- Volume
- 36
- Issue
- 4
- Pages
- 538-542
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W1979098009
- Cited by
- 305
- References
- 39
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 11 · 2023: 8 · 2022: 5 · 2021: 10 · 2020: 5 · 2019: 14 · 2018: 5 · 2017: 13 · 2016: 14 · 2015: 16 · 2014: 17 · 2013: 22 · 2012: 14
- FWCI
- 6.44
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Syncope and Autonomic Disorders
- Keywords
- obesity, obesity-related hypertension, baroreflex sensitivity, sympathetic nervous system, muscle sympathetic nerve activity, heart rate, baroreceptor stimulation, phenylephrine, sodium nitroprusside, cardiovascular regulation
- MeSH terms
- Adrenergic Fibers, Adult, Blood Pressure, Electrocardiography, Electrophysiology, Female, Heart Rate, Humans, Hypertension, Infusions, Intravenous, Male, Middle Aged, Nitroprusside, Obesity, Phenylephrine, Pressoreceptors, Thinness, Baroreflex, Sympathetic Fibers, Postganglionic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
